QUARTA, SANTINA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.837
AS - Asia 2.394
EU - Europa 1.574
SA - Sud America 603
AF - Africa 539
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 18
Totale 10.025
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.578
SG - Singapore 875
CN - Cina 552
BR - Brasile 411
IT - Italia 271
HK - Hong Kong 261
DE - Germania 208
FI - Finlandia 174
SE - Svezia 146
VN - Vietnam 137
PL - Polonia 112
RU - Federazione Russa 60
GB - Regno Unito 58
IN - India 56
FR - Francia 55
NL - Olanda 46
UA - Ucraina 43
AT - Austria 39
MX - Messico 32
AR - Argentina 28
IE - Irlanda 28
MA - Marocco 28
JP - Giappone 26
CA - Canada 25
EC - Ecuador 25
KR - Corea 23
PE - Perù 23
PY - Paraguay 23
TR - Turchia 23
UZ - Uzbekistan 23
AO - Angola 22
MN - Mongolia 22
ZA - Sudafrica 22
AE - Emirati Arabi Uniti 21
CO - Colombia 21
LY - Libia 21
PK - Pakistan 21
CY - Cipro 20
ID - Indonesia 20
JO - Giordania 20
VE - Venezuela 20
AL - Albania 19
AZ - Azerbaigian 19
ES - Italia 19
BB - Barbados 18
CH - Svizzera 18
CI - Costa d'Avorio 18
CM - Camerun 18
IQ - Iraq 18
JM - Giamaica 18
BF - Burkina Faso 17
CZ - Repubblica Ceca 17
GH - Ghana 17
PA - Panama 17
BE - Belgio 16
BZ - Belize 16
CL - Cile 16
IR - Iran 16
LA - Repubblica Popolare Democratica del Laos 16
LB - Libano 16
LC - Santa Lucia 16
NI - Nicaragua 16
UY - Uruguay 16
AU - Australia 15
BD - Bangladesh 15
CG - Congo 15
IS - Islanda 15
NE - Niger 15
TW - Taiwan 15
BJ - Benin 14
CR - Costa Rica 14
DJ - Gibuti 14
DZ - Algeria 14
EG - Egitto 14
GN - Guinea 14
HR - Croazia 14
KG - Kirghizistan 14
KZ - Kazakistan 14
LV - Lettonia 14
MY - Malesia 14
PH - Filippine 14
SD - Sudan 14
SK - Slovacchia (Repubblica Slovacca) 14
SN - Senegal 14
TH - Thailandia 14
AD - Andorra 13
CU - Cuba 13
GR - Grecia 13
ML - Mali 13
NZ - Nuova Zelanda 13
SA - Arabia Saudita 13
SO - Somalia 13
BO - Bolivia 12
CV - Capo Verde 12
DK - Danimarca 12
ET - Etiopia 12
GM - Gambi 12
GT - Guatemala 12
IL - Israele 12
KH - Cambogia 12
Totale 9.497
Salva come PNG Salva come JPEG
Città #
Singapore 518
Fairfield 502
Chandler 418
Ashburn 403
Woodbridge 283
Houston 242
Hong Kong 241
Jacksonville 231
Wilmington 231
Ann Arbor 220
Cambridge 195
Seattle 189
Santa Clara 156
Boardman 131
Beijing 116
Padova 105
Bytom 89
Helsinki 79
Princeton 79
Des Moines 72
Munich 69
San Diego 66
Nanjing 64
Medford 57
Los Angeles 56
New York 47
Ho Chi Minh City 41
Dearborn 40
Hefei 39
Roxbury 35
São Paulo 35
Turku 35
Buffalo 25
Hanoi 25
Nuremberg 25
Guangzhou 24
Shenyang 24
Dublin 23
Changsha 22
Tashkent 22
Amman 20
Ulan Bator 20
Baku 19
London 19
Luanda 19
Abidjan 18
Brooklyn 18
Chicago 18
Frankfurt am Main 17
Lima 17
Pune 17
Vienna 17
Panama City 16
Accra 15
Castries 15
Dong Ket 15
Jinan 15
Warsaw 15
Dakar 14
Jiaxing 14
Managua 14
Milan 14
Nanchang 14
Riga 14
Tokyo 14
Andorra la Vella 13
Bridgetown 13
Dallas 13
Djibouti 13
Kunming 13
Bamako 12
Bishkek 12
Conakry 12
Hebei 12
Kigali 12
Lusaka 12
Montevideo 12
Niamey 12
Phnom Penh 12
San Francisco 12
Stockholm 12
Tripoli 12
Vientiane 12
Antananarivo 11
Apia 11
Guayaquil 11
Havana 11
Johannesburg 11
Kampala 11
Kingston 11
Ouagadougou 11
Phoenix 11
Podgorica 11
Reykjavik 11
Shanghai 11
Tianjin 11
Tirana 11
Banjul 10
Brasília 10
Cotonou 10
Totale 6.087
Salva come PNG Salva come JPEG
Nome #
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 269
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 241
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 234
Synthesis, chemical characterization and cancer cell growth-inhibitory activities of Cu(ii) and Ru(iii) aliphatic and aromatic dithiocarbamato complexes 224
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 211
Biological and clinical implications of HBV infection in peripheral blood mononuclear cells 188
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 186
SERPINB3 induces epithelial-mesenchymal transition. 186
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 185
Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells 183
1-Piperidine Propionic Acid Protects from Septic Shock Through Protease Receptor 2 Inhibition 174
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy 169
Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells 169
SERPINB3, apoptosis and autoimmunity 167
Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma 164
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 163
Exogenous Administration of SERPINB3 Inhibits Cell Reprogramming 162
Hepatic progenitor cells express SerpinB3 161
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice. 158
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 158
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 157
Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis 157
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 154
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells. 151
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 146
Labelled micelles for the delivery of cytotoxic Cu(II) and Ru(III) compounds in the treatment of aggressive orphan cancers: design and biological in vitro data 137
Biodistribution of Intratracheal, Intranasal, and Intravenous Injections of Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles in a Mouse Model for Drug Delivery Studies 135
Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis 133
HEPATIC PROGENITOR CELLS OVEREXPRESS SERPINB3 IN A MOUSE MODEL OF FULMINANT HEPATITIS 131
Activation of pivotal cell cycle proteins and inhibition of apoptosis by SCCA1 in HepG2 cells 123
The protease-inhibitor SerpinB3 as a critical modulator of the stem-like subset in human cholangiocarcinoma 121
The Protease Activated Receptor 2 - CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of Non-Alcoholic Steatohepatitis 120
Deregulation of Squamous Cell Carcinoma Antigen (SCCA) expression in B lymphocytes in patients with chronic hepatitis C 120
1-Piperidine Propionic Acid as an Allosteric Inhibitor of Protease Activated Receptor-2 119
SERPINB3 AS A PRO-INFLAMMATORY MEDIATOR IN THE PROGRESSION OF EXPERIMENTAL NON-ALCOHOLIC FATTY LIVER DISEASE. 118
Monitoring SCCA-IgM complex predicts liver disease progression in patients with chronic hepatitis and cirrhosis 117
RUOLO DI SERPINB3 ELLA PROGRESSIONE DELLA MALATTIA EPATICA 116
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 114
SERPINB3 INDUCES EPITHELIAL MESENCHYMAL TRANSITION 113
Circulating Squamous Cell Carcinoma Antigen-IgM complexes as novel biomarkers for hepatocellular carcinoma 111
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 110
SCCA overexpression induces cell proliferation and down-regulation of the adhesion system 110
Vescicole extracellulari da cellule geneticamente modificate iperesprimenti SerpinB3 per uso come agenti terapeutici 110
ESPRESSIONE DELLA SERPINA SCCA IN CELLULE MONONUCLEATE DI SANGUE PERIFERICO IN PAZIENTI CO INFEZIONE CRONICA DA HCV 109
DEREGOLAZIONE DELL’ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) NEI LINFOCITI B IN PAZIENTI INFETTI DA HCV 108
HPYPOXYA UP-REGULATES SERPINB3 IN HEPATIC CANCER CELLS: A HIF-2a ASSOCIATED EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 107
SERPINB3 modulates TGF-beta expression in chronic liver disease. 105
HYPOXIA UP-REGULATES SERPINB3 IN HEPG2 CELLS: A REDOX SENSITIVE EVENT RELATED TOEPITHELIAL TO MESENCHYMAL TRANSITIONAND INVASIVENESS 104
Espressione della serpina SCCA in cellule mononucleate di sangue periferico in pazienti con infezione cronica da HCV 103
POLIMORFISMO DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E PROGRESSIONE DELLA MALATTIA EPATICA NELL’INFEZIOE HCV 103
CHARACTERIZATION OF SCCA-1(SERPINB3) ISOFORMS IN HEPATOCELLULAR CARCINOMA 103
SQUAMOUS CELL CARCINOMA ANTIGEN (SCCA) ENHANCES LIVER REGENERATION AFTER PARTIAL HEPATECTOMY 103
SerpinB3/Protease Activated Receptor-2 Axis Is Essential for SARS CoV-2 Infection 102
HCC invasiveness induced by SCCA is associated with nuclear beta-catenin accumulation 102
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 102
SCCA EXPRESSION IN PBMCs IN PATIENTS WITH CHRONIC HEPATITIS C 101
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 100
DOWNREGULATION OF SURFACE SQUAMOUS CELL CARCINOMA ANTIGEN EXPRESSION AND CD27+ MOLECULE ON B LYMPHOCYTES IN PATIENTS WITH CHRONIC HEPATITIS C 99
OVEREXPRESSION OF SERPINB3 IN HEPATIC PROGENITOR CELLS IN A MOUSE MODEL OF ACUTE LIVER INJURY 97
COMPORTAMENTO DI SCCA-IgM NEL SIERO DI BAMBINI HBeAg POSITIVI SEGUITI NEL TEMPO 97
SERPINB3 PROMUOVE L’INVASIVITA’ CELLULARE 97
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition 95
SerpinB3 administration protects liver against ischemia-reperfusion injury 93
SCCA1-IGM AND SCCA2-IGM COMPARED WITH TOTAL SCCA-IGM FOR DIAGNOSIS OF HEPATOCELLULAR CARCINOMA 93
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo 91
SEX DEPENDENT IL-6 DEREGULATION BY SERPINB3 IN A TRANSGENIC MOUSE MODEL 89
Squamous cell carcinoma antigen (SCCA) expression and CD27+ memory B lymphocytes in patients with chronic hepatitis C and systemic lupus erythematosus (SLE) 87
Serum SCCA IgM complexes increase over time and HCC development in cirrhotic patients 85
ESPRESSIONE DI TGF-b1 NELLA MALATTIA EPATICA EVOLUTIVA 85
PRO-ONCOGENIC EFFECT OF SQUAMOUS CELL CARCINOMA ANTIGEN VIA WNT/BETA-CATENIN SIGNALING 84
SERPINB3 AND TGF-BETA IN CHRONIC LIVER DISEASE 84
ESPRESSIONE DI SCCA (SQUAMOUS CELL CARCINOMA ANTIGEN) E CELLULE B DELLA MEMORIA IN CORSO DI INFEZIONE DA VIRUS DELL’EPATITE C 84
CELLULE PROGENITRICI EPATICHE ESPRIMONO SERPINB3 IN UN MODELLO MURINO DI EPATITE FULMINANTE 82
SERPINB3 UP-REGULATION BY HYPOXIA IN HEPG2 CELLS : A HIF-2ALPHA AND REDOX SENSITIVE EVENT RELATED TO INVASIVENESS AND EPITHELIAL TO MESENCHYMAL TRANSITION 76
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE OF VIRAL ETIOLOGY 73
MODULAZIONE DEI LIVELLI DI IL-6 NELLA RIGENERAZIONE EPATICA DA PARTE DI SERPINB3 ED ESTROGENI. ANALISI IN UN MODELLO DI TOPO TRANSGENICO 73
Inhibition of Protease-Activated Receptor-2 Activation in Parkinson’s Disease Using 1-Piperidin Propionic Acid 72
Hepatotropic viruses: new insights in pathogenesis and treatment 69
SERPINB3 AND TGF-BETA1 CORRELATION IN CHRONIC LIVER DISEASE 66
A New Assay for Quantitative Determination of Pres1-Encoded Protein in Patients Infected with Hepatitis B and Delta Viruses 60
The impact of serpinB3-PD polymorphism on the prognosis of patients with hepatocellular carcinoma 11
Totale 10.069
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.587
article - articoli 25.632
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 313
selected - selezionate 0
volume - volumi 0
Totale 57.532
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021620 0 0 0 0 24 65 20 39 101 173 98 100
2021/2022711 19 103 79 58 27 47 32 64 33 9 81 159
2022/2023885 140 88 18 96 153 146 0 79 107 6 38 14
2023/2024457 14 65 67 29 49 67 39 17 10 18 35 47
2024/20252.104 10 202 75 99 212 67 89 130 152 99 413 556
2025/20263.295 402 676 970 1.001 246 0 0 0 0 0 0 0
Totale 10.069